CML

Clinical trials for CML explained in plain language.

Never miss a new study

Get alerted when new CML trials appear

Sign up with your email to follow new studies for CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 3 Terminated 1

New drug may make stem cell transplants safer for older patients

Disease control Ongoing

This early-phase trial tests whether the drug itacitinib can prevent cytokine release syndrome (a severe inflammatory reaction) after a mini stem cell transplant in people aged 60 and older with certain blood cancers. The study also aims to see if itacitinib allows doctors to use…

Matched conditions: CML

Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control

Last updated Jun 26, 2026 18:40 UTC

CML

Get alerted when new CML trials appear

New drug may make stem cell transplants safer for older patients